Statistics

Total Visits

Views
The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial13

Select a period of time:

Number of views in the range

Views
The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial7

Views

Views
May 20243
June 20242
July 20241
August 20240
September 20240
October 20241
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
 

Top cities views

Views
Fort Worth2
Chicago1